AGT and atrial fibrillation: The wild-type (WT) mice were injected with rAAV9-shBhlhe40 or its control vector (rAAV9-shCON) for 2 weeks and then treated with Ang II (2,000 ng/kg/min) infusion for additional 3 weeks to induce AF (Figure 3A).